LEXX: Lexaria Bioscience Corp. Stock

by  •  • Comments Off on LEXX: Lexaria Bioscience Corp. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 30.54
Enterprise Value ($M) 22.08
Book Value ($M) 9.39
Book Value / Share 0.54
Price / Book 3.25
NCAV ($M) 8.43
NCAV / Share 0.48
Price / NCAV 3.62

Profitability (mra)
Return on Invested Capital (ROIC) -0.77
Return on Assets (ROA) -2.02
Return on Equity (ROE) -2.17

Liquidity (mrq)
Quick Ratio 29.64
Current Ratio 29.64

Balance Sheet (mrq) ($M)
Current Assets 8.83
Assets 9.79
Liabilities 0.40
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.46
Operating Income -5.70
Net Income -5.80
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -4.96
Cash from Investing -0.19
Cash from Financing 10.32

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Invenomic Capital Management LP 4.70 -22.45
02-14 13D/A Boos Wayne W 4.67 6.67

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 1,481 18,586 7.97
2025-02-03 9,037 31,580 28.62
2025-01-31 11,171 46,743 23.90
2025-01-30 31,561 67,205 46.96

(click for more detail)

Similar Companies
KRRO – Korro Bio, Inc. KTTA – Pasithea Therapeutics Corp.
KZR – Kezar Life Sciences, Inc. LFVN – LifeVantage Corporation
LGVN – Longeveron Inc.


Financial data and stock pages provided by
Fintel.io